2013
DOI: 10.3389/fphar.2013.00060
|View full text |Cite
|
Sign up to set email alerts
|

Brain effects of nicotine and derived compounds

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
5
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 18 publications
(19 reference statements)
0
5
0
Order By: Relevance
“…It is commonly known that long-term exposure to nicotine causes nAChR desensitization ( 16 ), leading to memory impairment in otherwise healthy individuals ( 17 ). Such nicotine-induced cognitive dysfunction is associated with several mechanisms, including activation of the phosphodiesterase-5 (PDE-5) signaling pathway and inhibition of estrogen biosynthesis ( 18 , 19 ). In particular, nicotine stimulates the expression of PDE-5 ( 19 , 20 ), which plays a role in cleaving cyclic guanosine monophosphate and cyclic adenosine monophosphate that activate downstream signaling pathways contributing to memory impairment ( 21 – 23 ).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…It is commonly known that long-term exposure to nicotine causes nAChR desensitization ( 16 ), leading to memory impairment in otherwise healthy individuals ( 17 ). Such nicotine-induced cognitive dysfunction is associated with several mechanisms, including activation of the phosphodiesterase-5 (PDE-5) signaling pathway and inhibition of estrogen biosynthesis ( 18 , 19 ). In particular, nicotine stimulates the expression of PDE-5 ( 19 , 20 ), which plays a role in cleaving cyclic guanosine monophosphate and cyclic adenosine monophosphate that activate downstream signaling pathways contributing to memory impairment ( 21 – 23 ).…”
Section: Introductionmentioning
confidence: 99%
“…In particular, nicotine stimulates the expression of PDE-5 ( 19 , 20 ), which plays a role in cleaving cyclic guanosine monophosphate and cyclic adenosine monophosphate that activate downstream signaling pathways contributing to memory impairment ( 21 – 23 ). Nicotine also blocks estrogen synthase (aromatase) in the brain, which is important for estrogen biosynthesis ( 18 , 24 ). Estrogen activates estrogen receptors in the brain, which function as transcriptional factors and enhance the expression of several neurotransmitters (including glutamate, acetylcholine, serotonin and noradrenaline), and thus stimulate the neuronal circuits required for memory encoding ( 25 ).…”
Section: Introductionmentioning
confidence: 99%
“…Cotinine (73), a predominant metabolite of nicotine (74), is an important -lactam with a wide range of pharmacological properties. 54 Inspired by its diverse medicinal properties, in 2015, Vazquez and co-workers 55 developed a two-step Ugi-4CR/post-condensation strategy for the synthesis of highly substituted cotinine and iso-cotinine ana-logues 80 (Scheme 18). First, an InCl 3 -catalyzed multicomponent reaction was performed between 3-chloropropionic acid (75), 3-pyridine aldehyde, amines, and isocyanides to afford Ugi adducts 76, which subsequently gave -lactams 80 in moderate to excellent yields via t-BuOK-mediated cyclization under MW heating conditions.…”
Section: Scheme 16 Syntheses Of -Lactams 69mentioning
confidence: 99%
“…1A). 6 Pre-clinical studies have shown that cotinine facilitates the elimination of fear memories and improves attention and working memory in a mouse model for Alzheimer disease (AD), 7 reduces fear and anxiety in a mouse model of post-traumatic stress disorder (PTSD), 8 as well as antipsychotic druglike properties. 5 Cotinine (2) has proved to be 100 times less toxic than nicotine (1) with a longer plasma half-life of 19-24 h with respect to nicotine (2-3 h), apart from not having addictive or cardiovascular effects on humans, despite its structural similarity to nicotine (1).…”
Section: Introductionmentioning
confidence: 99%